Cargando…

Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial

Chemotherapy is not effective for hepatocellular carcinoma (HCC). HMG-CoA redutase inhibitors have cytostatic activity for cancer cells, but their clinical usefulness is unknown. To investigate whether pravastatin, a potent HMG-CoA reductase inhibitor, prolongs survival in patients with advanced HCC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawata, S, Yamasaki, E, Nagase, T, Inui, Y, Ito, N, Matsuda, Y, Inada, M, Tamura, S, Noda, S, Imai, Y, Matsuzawa, Y
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2001
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363838/ https://www.ncbi.nlm.nih.gov/pubmed/11286466 http://dx.doi.org/10.1054/bjoc.2000.1716

Ejemplares similares

Modulation of the mevalonate pathway and cell growth by pravastatin and d-limonene in a human hepatoma cell line (Hep G2).
por: Kawata, S., et al.
Publicado: (1994)

Effect of Pravastatin, a Potent 3‐Hydroxy‐3‐methylgliitaryl‐coenzyme A Reductase Inhibitor, on Survival of AH130 Hepatoma‐bearing Rats
por: Kawata, Sumio, et al.
Publicado: (1992)

Manumycin and gliotoxin derivative KT7595 block Ras farnesylation and cell growth but do not disturb lamin farnesylation and localization in human tumour cells.
por: Nagase, T., et al.
Publicado: (1997)

Effect of pravastatin on the survival of patients with advanced gastric cancer
por: Bujanda, Luis, et al.
Publicado: (2015)

Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma
por: Ito, Y, et al.
Publicado: (2001)

Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma
por: Ito, Y, et al.
Publicado: (1999)

Efficacy and Safety of the Combination of Pravastatin and Sorafenib for the Treatment of Advanced Hepatocellular Carcinoma (ESTAHEP Clinical Trial)
por: Riaño, Ioana, et al.
Publicado: (2020)

Tailoring of Geranium Oil-Based Nanoemulsion Loaded with Pravastatin as a Nanoplatform for Wound Healing
por: Rizg, Waleed Y., et al.
Publicado: (2022)

The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma
por: Ito, Y, et al.
Publicado: (2000)

Betel quid chewing as a risk factor for hepatocellular carcinoma: a case-control study
por: Tsai, J F, et al.
Publicado: (2001)

Elevated Levels of Plasma Transforming Growth Factor‐β in Patients with Hepatocellular Carcinoma
por: Shirai, Yasuhiro, et al.
Publicado: (1992)

Met/HGF receptor modulates bcl-w expression and inhibits apoptosis in human colorectal cancers
por: Kitamura, S, et al.
Publicado: (2000)

Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan
por: Sheu, J-C, et al.
Publicado: (1999)

Evaluation of the effects of photodynamic therapy with phosphorus 31 magnetic resonance spectroscopy
por: Nishiwaki, M, et al.
Publicado: (1999)

Identification and characterization of a novel human hepatocellular carcinoma-associated gene
por: Wang, Z-X, et al.
Publicado: (2001)

New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis
por: Tian, J, et al.
Publicado: (1999)

Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers
por: Yu, M-W, et al.
Publicado: (1999)

Proline-rich antimicrobial peptide, PR-39 gene transduction altered invasive activity and actin structure in human hepatocellular carcinoma cells
por: Ohtake, T, et al.
Publicado: (1999)

Multi-institutional randomized clinical study on the comparative effects of intracavital chemotherapy alone versus immunotherapy alone versus immunochemotherapy for malignant effusion
por: Nio, Y, et al.
Publicado: (1999)

VEGF Overexpression Predicts Poor Survival in Hepatocellular Carcinoma
por: Choi, Sae Byeol, et al.
Publicado: (2017)

Expression of Transforming Growth Factor‐β1 mRNA in Human Hepatocellular Carcinoma
por: Ito, Nobuyuki, et al.
Publicado: (1990)

Tumour inoculation site-dependent induction of cachexia in mice bearing colon 26 carcinoma
por: Matsumoto*, T, et al.
Publicado: (1999)

Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization
por: Miyasaka, Y, et al.
Publicado: (2001)

Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma
por: Toshikuni, N, et al.
Publicado: (2000)

Apoptosis and p53 status predict the efficacy of postoperative administration of UFT in non-small cell lung cancer
por: Tanaka, F, et al.
Publicado: (2001)

Nuclear translocation of beta-catenin in colorectal cancer
por: Kobayashi, M, et al.
Publicado: (2000)

Pravastatin But Not Simvastatin Improves Survival and Neurofunctional Outcome After Cardiac Arrest and Cardiopulmonary Resuscitation
por: Bergt, Stefan, et al.
Publicado: (2017)

Downregulation and forced expression of EWS-Fli1 fusion gene results in changes in the expression of G (1) regulatory genes
por: Matsumoto, Y, et al.
Publicado: (2001)

Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma
por: Mihara, M, et al.
Publicado: (1999)

Impaired FHIT expression characterizes serous ovarian carcinoma
por: Ozaki, K, et al.
Publicado: (2001)

Clinicopathologic significance of sialyl Le (x)expression in advanced gastric carcinoma
por: Futamura, N, et al.
Publicado: (2000)

Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer
por: Umemoto, M, et al.
Publicado: (2001)

The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer
por: Kajita, T, et al.
Publicado: (2001)

Immunological inflammatory biomarkers as prognostic predictors for advanced hepatocellular carcinoma
por: Nakano, M., et al.
Publicado: (2021)

Effect of Pravastatin on Echocardiographic Circulation Parameters in Dogs
por: ARITA, Shinji, et al.
Publicado: (2013)

Effects of Pravastatin in Adriamycin-Induced Nephropathy in Rats
por: Mansouri, Esrafil, et al.
Publicado: (2018)

Pravastatin-Induced Eczematous Eruption Mimicking Psoriasis
por: Salna, Michael P., et al.
Publicado: (2017)

Effect of Pravastatin and Simvastatin on the Reduction of Cytochrome C
por: Csomó, Krisztián, et al.
Publicado: (2022)

Pravastatin-induced rhabdomyolysis and purpura fulminans in a patient with chronic renal failure
por: Kato, Kazuya, et al.
Publicado: (2015)

DNA methylation analysis at distal and proximal promoter regions of the oestrogen receptor gene in breast cancers
por: Iwase, H, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_k48t4b7c3df1nt65jntv1r8dks